Global Regenex provides advanced autologous stem cell transplants as a treatment option for patients with lymphoma, a type of cancer that originates in the lymphatic system. This treatment involves harvesting and reinfusing the patient’s own stem cells, allowing for high-dose chemotherapy to target the cancer while minimizing the risk of long-term damage to healthy cells.